Sonoma Pharma
SNOA1.1302.73% ( +0.030 )
Q4 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Sonoma Pharma(SNOA) the Revenue is 5.561 M (+48.14%);the EBIT is -351 K (+46.49%);the EPS is -0.335 (+30.39%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B48.14%
----
----
EBIT
-0.00B46.49%
----
----
EPS
-0.334930.39%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf